Support Quality Journalism: Help Us Cover Critical Issues Like Obesity and Health

Support The Independent’s Journalism

Your support helps us cover crucial issues like reproductive rights and climate change. The Independent investigates important stories, from financial activities of major figures to documentaries like ‘The A Word’, focused on women’s reproductive rights.

In this critical time for the US, our reporters need to be on the ground. Your donations help us send journalists to gather facts and present balanced views.

The Independent is trusted across the political spectrum. Unlike many outlets, we don’t use paywalls, believing everyone should access quality journalism, funded by those who can afford it.

Your support is vital.

Public Interest in Anti-Obesity Drugs

A recent survey from Ipsos reveals that 24% of Brits would accept free anti-obesity drugs from the NHS. Only 7% would pay privately for these medications, which costs about £180 to £220 each month.

Regarding body image, 40% of respondents identify as overweight or obese. Knowledge of weight-loss drugs varies by age, with younger individuals showing more understanding than older groups.

Currently, Ozempic is available on the NHS for type 2 diabetes, while Wegovy is prescribed for weight loss under specific criteria. Mounjaro has also been recommended as a treatment for obesity.

Health officials consider a phased rollout of these medications due to high demand. An NHS representative stated that weight-loss drugs are important but not a cure-all. Potential side effects include nausea and vomiting.

Public opinion is divided on whether the NHS should offer these drugs. About 37% support their availability, while 32% oppose it. The NHS is committed to various weight-loss initiatives and safe medication rollout.

Prime Minister Sir Keir Starmer and Health Secretary Wes Streeting advocate for weight-loss jabs, suggesting they could help reduce unemployment and ease pressure on healthcare services.